Pulmonary embolism (PE) is a serious and potentially life-threatening medical condition that affects many people around the world. It is caused when a blood clot travels to the lungs, blocking the flow of oxygenated blood and resulting in potentially fatal complications. PE is also known as the “silent killer” because it often has no warning signs or symptoms and can be difficult to diagnose. It is important for doctors to understand the risk factors associated with PE and to be able to recognize the signs and symptoms in order to provide timely and effective treatment.
Pulmonary embolism is a medical emergency that occurs when a blockage, usually a blood clot, travels from one part of the body to the lungs. The blockage, called an embolus, can be caused by a variety of factors, including deep vein thrombosis (DVT), which is a clot in the veins of the leg. The embolus lodges in the pulmonary arteries, blocking the flow of oxygenated blood to the lungs. This can cause a variety of serious complications, including difficulty breathing, chest pain, and even death.
There are several risk factors that can increase the likelihood of developing pulmonary embolism. These include: • Age: People over the age of 60 are more likely to develop PE than younger individuals. • Gender: Women are more likely to develop PE than men. • Obesity: People who are overweight or obese are at a higher risk for developing PE. • Smoking: Smoking increases the risk of developing PE. • Inactivity: People who are sedentary or who have a history of long periods of inactivity are at a higher risk for developing PE. • Family history: People with a family history of blood clots or PE are more likely to develop PE. • Surgery: People who have recently had surgery, especially major surgery, are at an increased risk of developing PE. • Pregnancy: Pregnant women are more likely to develop PE due to changes in blood flow and clotting factors.
The signs and symptoms of PE can vary from person to person and can range from mild to severe. Some of the most common symptoms include: • Shortness of breath • Chest pain • Coughing • Sweating • Rapid heart rate • Lightheadedness • Fainting It is important to note that some people may not experience any symptoms at all, making PE even more difficult to diagnose.
In order to diagnose PE, doctors will typically use a combination of tests, including a physical exam, chest X-ray, CT scan, echocardiogram, and blood tests. Treatment for PE usually involves the use of anticoagulant medications to help prevent the formation of new clots and to reduce the risk of further complications. In some cases, surgery may be required to remove the clot from the lungs.
Pulmonary embolism is a serious and potentially life-threatening medical condition that affects many people around the world. It is important for doctors to be aware of the risk factors associated with PE and to be able to recognize the signs and symptoms in order to provide timely and effective treatment. With early diagnosis and treatment, the risk of serious complications and death can be greatly reduced.
1.
Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.
2.
Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.
3.
BRAF Inhibition in Pediatric Ameloblastoma of the Jaw
4.
Novel Psychedelic Promising on Resistant Depression
5.
Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer
1.
Transformative Advances in Hematology in Daily Practice
2.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
3.
Myeloproliferative Disorders: Causes, Symptoms and Treatment Options
4.
Evidence-Based Insights in Oncology for Specialists
5.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
2.
Early warning sings of camcer that need medical attention
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Expert Perspectives on Hematology
5.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation